Get the Daily Brief

All action, no filler. BioBriefs delivers biotech’s 10 must-know updates, every morning.

Latest Biotech News

Single-Cell Genomics Redefines Skin Cancer Complexity

August 23, 2025

Recent advances in single-cell DNA analysis have uncovered the profound genomic diversity within cutaneous squamous cell carcinoma (CSCC), a prevalent and aggressive skin cancer. By dissecting...

FDA Clears Ionis’ Therapy for Rare Swelling Disorder

August 23, 2025

Ionis Pharmaceuticals received FDA approval for Dawnzera (donidalorsen), an antisense therapy to prevent attacks in hereditary angioedema (HAE). The approval followed positive phase III trial...

Gilead Acquires Interius to Enter In Vivo CAR-T Therapy Race

August 23, 2025

Gilead Sciences, through its Kite Pharma subsidiary, acquired Interius BioTherapeutics for $350 million, gaining access to single-shot in vivo CAR-T therapy technology aimed at simplifying cell...

AI Discovers Novel Antibiotics and Cancer Detection Advances

August 23, 2025

Artificial intelligence is accelerating drug discovery and diagnostics with notable breakthroughs. Researchers at MIT developed a generative AI model producing novel antibiotic structures from...

Quantum Technology Makes Strides in Computing and Networking

August 23, 2025

Major advancements in quantum computing and networking have been reported. At the University of Sydney, researchers have experimentally realized efficient quantum logic gates that reduce qubit...

New Biomarkers and Molecular Targets in Cancer and Liver Disease

August 23, 2025

Emerging molecular biomarkers and targets are reshaping oncology and hepatology. The GATOR1 complex was identified as a tumor suppressor in aggressive Myc-driven lymphoma through genome-wide...

Breakthroughs in Alzheimer’s Disease Linking Infection and Protein Regulation

August 23, 2025

New insights into Alzheimer’s pathogenesis involve microbial and protein regulatory mechanisms. A National Institute on Aging grant supports Lighthouse Pharmaceuticals’ trial of LHP588, a...

Innovations in Battery Technology and Energy Storage

August 23, 2025

Cutting-edge studies address key challenges in energy storage and battery health. Researchers have developed AI-driven models for estimating lithium-ion battery health with enhanced accuracy,...

AI and Machine Learning Catalyze Biotech and Pharma Progress

August 23, 2025

Artificial intelligence is rapidly reshaping drug discovery, diagnostics, and therapeutic optimization. Natera introduced AI foundational models integrating genomic, clinical, and imaging data to...

Regulatory and Funding Dynamics Shape Biotech Industry Landscape

August 23, 2025

Biotech industry navigates evolving regulatory and financial currents. The FDA has accelerated review timelines, with Ionis securing rapid approval for its rare disease therapy Dawnzera and...

FDA Approves Ionis’ Dawnzera for Rare Swelling Disorder

August 22, 2025

Ionis Pharmaceuticals received FDA approval for Dawnzera (donidalorsen), a prophylactic antisense therapy for hereditary angioedema (HAE), a rare genetic condition causing painful swelling...

Gilead Strengthens In Vivo CAR-T Cell Therapy with Interius Acquisition

August 22, 2025

Gilead Sciences, through its Kite Pharma subsidiary, acquired Interius BioTherapeutics for $350 million to expand its capabilities in in vivo CAR-T cell therapies. This approach genetically...

Artificial Intelligence Accelerates Protein and Drug Discovery

August 22, 2025

AI-driven approaches are revolutionizing biotech research, as demonstrated by multiple studies and products. MIT researchers developed generative AI models to propose novel antibiotic structures,...

New Molecular Targets and Mechanisms in Cancer and Immunotherapy

August 22, 2025

Recent research offers novel insights into cancer biology and immunotherapy resistance. Notable findings include identification of the GATOR1 complex as a tumor suppressor in Myc-driven lymphoma...

Advances in Alzheimer’s Disease Therapeutics and Pathogenesis

August 22, 2025

Lighthouse Pharmaceuticals received nearly $50 million from the NIH’s National Institute on Aging to support a phase 2 trial targeting bacterial involvement in Alzheimer's associated with...

Quantum and Photonic Technologies for Biotech and Communications

August 22, 2025

Researchers are making significant strides in quantum networking and photonic device integration. The University of Innsbruck demonstrated transformative quantum network nodes capable of storing...

Innovations in Diagnostic and Imaging Technologies

August 22, 2025

Cutting-edge diagnostic tools are reshaping disease detection and management. Uppsala University utilized AI to detect prostate cancer cases overlooked by pathologists in biopsies. The University...

Major Biopharma Financings and Corporate Developments

August 22, 2025

In the biopharma financing arena, several substantial fundraises and strategic corporate moves were reported. Kriya Therapeutics raised $313 million to advance gene therapies for chronic diseases...

Regulatory Changes Improve Drug Safety Transparency and Review Processes

August 22, 2025

The FDA has initiated daily publication of adverse event reports via its Adverse Event Reporting System, transitioning from quarterly updates to enhance public accessibility and safety monitoring....

FDA Approves Ionis' RNA-Targeted Therapy for Rare Swelling Disorder

August 22, 2025

Ionis Pharmaceuticals received FDA approval for Dawnzera (donidalorsen), an antisense RNA therapy designed to prevent attacks in patients with hereditary angioedema (HAE), a rare genetic disorder...